1-4 of 4
Tyler Maclay
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Targeting Homologous Recombination in Lymphoid Malignancies: Evaluation of Four Small Molecule Inhibitors of RAD51

Melinda Day, PhD, Tyler Maclay, Amber Cyr, Muneer G Hasham, PhD, Kin-hoe Chow, ED Keniston, Kevin Mills, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2080.
https://doi.org/10.1182/blood-2019-131747
Published: 2019
Journal Articles

CYT01B, a Novel RAD51 Inhibitor, Act Synergistically with Both Targeted and Chemotherapeutic Anti-Cancer Agents

Tyler Maclay, Joseph Vacca, Casey McComas, Alfredo Castro, Melinda Day, PhD, Kevin Mills, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3963.
https://doi.org/10.1182/blood-2018-99-119373
Published: 2018
Journal Articles

A Small Molecule RAD51 Inhibitor Preferentially Affects Cells Expressing High Cytidine Deaminase Activity

Kevin Mills, PhD, Amber Cyr, Tyler Maclay, Melinda Day, Muneer G Hasham, PhD, Andre Khalil
Journal: Blood
Blood (2017) 130 (Supplement 1): 4627.
https://doi.org/10.1182/blood.V130.Suppl_1.4627.4627
Published: 2017
Journal Articles

Synthetic Lethality Targeting the Aid/RAD51 Axis for Treatment of AICDA-Expressing Lymphoma

Kevin Mills, PhD, Amber Cyr, Tyler Maclay, Melinda Day, Darryl Patrick, Sophie-Dorothee Clas, Muneer G Hasham, PhD, Kin-hoe Chow
Journal: Blood
Blood (2017) 130 (Supplement 1): 4628.
https://doi.org/10.1182/blood.V130.Suppl_1.4628.4628
Published: 2017